Onderneming Straumann Holding AG Deutsche Boerse AG
Aandelen
QS51
CH1175448666
Medische apparatuur, benodigdheden & distributie
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
77,8 EUR | +1,46% | -.--% | -.--% |
30/04 | Transcript : Straumann Holding AG, Q1 2024 Sales/ Trading Statement Call, Apr 30, 2024 | |
30/04 | Straumann omzet in Q1 gestegen; FY24 Vooruitzichten bevestigd | MT |
Vakgebied
Aantal werknemers: 10 832
Verkoop per activiteit
CHF in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
EMEA
43,7
%
| - | - | 1 054 | 43,7 % | - |
North America
29,0
%
| 703 | 30,3 % | 700 | 29,0 % | -0,42% |
Asia Pacific
18,7
%
| 423 | 18,2 % | 451 | 18,7 % | +6,76% |
Latin America
8,6
%
| 179 | 7,7 % | 207 | 8,6 % | +16,09% |
Verkoop per regio
CHF in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Other
35,8
%
| 832 | 35,9 % | 864 | 35,8 % | +3,80% |
United States
25,7
%
| 609 | 26,2 % | 619 | 25,7 % | +1,69% |
China
10,7
%
| 244 | 10,5 % | 259 | 10,7 % | +6,18% |
Germany
10,1
%
| 238 | 10,2 % | 242 | 10,1 % | +1,92% |
Brazil
6,4
%
| 135 | 5,8 % | 153 | 6,4 % | +13,71% |
France
5,2
%
| 112 | 4,8 % | 125 | 5,2 % | +11,80% |
Japan
4,5
%
| 112 | 4,8 % | 109 | 4,5 % | -2,64% |
Switzerland
1,7
%
| 39 | 1,7 % | 40 | 1,7 % | +1,74% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-01-07 | |
Yang Xu
DFI | Director of Finance/CFO | 45 | 21-08-23 |
Sébastien Roche
COO | Chief Operating Officer | - | 01-04-22 |
Chief Tech/Sci/R&D Officer | 52 | 01-10-21 | |
Investor Relations Contact | - | - | |
Patrick Loh
PRN | Corporate Officer/Principal | 57 | 01-01-17 |
Holger Haderer
PRN | Corporate Officer/Principal | 55 | 01-01-20 |
Andreas Meier
LAW | General Counsel | 57 | - |
Matthias Schupp
PRN | Corporate Officer/Principal | 60 | - |
Jason Forbes
PRN | Corporate Officer/Principal | - | 19-04-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
H. C. Straumann
BRD | Director/Board Member | 61 | 01-01-90 |
Olivier Filliol
BRD | Director/Board Member | 57 | 05-04-23 |
Marco Gadola
BRD | Director/Board Member | 61 | 01-01-20 |
Petra Rumpf
CHM | Chairman | 57 | 09-04-21 |
Regula Wallimann
BRD | Director/Board Member | 57 | 07-04-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 159 455 239 | 107 232 760 ( 67,25 %) | 11 758 ( 0,007374 %) | 67,25 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Institut Straumann AG
Institut Straumann AG Medical/Nursing ServicesHealth Services Institut Straumann AG operates a dentistry group. It engages in the research, development and manufacturing dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions. The company is headquartered in Basel, Switzerland. |
Medical/Nursing Services
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,12% | 19,55 mld. | |
+10,62% | 14,82 mld. | |
+13,18% | 10,5 mld. | |
-12,19% | 2,22 mld. | |
+4,55% | 1,83 mld. | |
+34,92% | 1,64 mld. | |
0,00% | 397 mln. | |
+81,25% | 193 mln. | |
+19,61% | 94,06 mln. |
- Beurs
- Aandelen
- Koers STMN
- Koers QS51
- Onderneming Straumann Holding AG